Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening.

Shimada Y, Hirano M, Nishimura Y, Tanaka T.

PLoS One. 2012;7(12):e52549. doi: 10.1371/journal.pone.0052549. Epub 2012 Dec 26.

2.

Appetite regulation: the central role of melatonin in Danio rerio.

Piccinetti CC, Migliarini B, Olivotto I, Coletti G, Amici A, Carnevali O.

Horm Behav. 2010 Nov;58(5):780-5. doi: 10.1016/j.yhbeh.2010.07.013. Epub 2010 Aug 5.

PMID:
20692259
3.

A high-throughput assay for quantifying appetite and digestive dynamics.

Jordi J, Guggiana-Nilo D, Soucy E, Song EY, Lei Wee C, Engert F.

Am J Physiol Regul Integr Comp Physiol. 2015 Aug 15;309(4):R345-57. doi: 10.1152/ajpregu.00225.2015. Epub 2015 Jun 24.

4.

Food intake and appetite control in a GH-transgenic zebrafish.

Dalmolin C, Almeida DV, Figueiredo MA, Marins LF.

Fish Physiol Biochem. 2015 Oct;41(5):1131-41. doi: 10.1007/s10695-015-0074-5. Epub 2015 May 20.

PMID:
25990920
5.

Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.

Hsieh YS, Chen PN, Yu CH, Chen CH, Tsai TT, Kuo DY.

Neurotoxicology. 2015 May;48:131-41. doi: 10.1016/j.neuro.2015.03.011. Epub 2015 Mar 28.

PMID:
25825358
6.

Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?

Tallett AJ, Blundell JE, Rodgers RJ.

Behav Brain Res. 2010 Feb 11;207(1):174-81. doi: 10.1016/j.bbr.2009.10.004. Epub 2009 Oct 8.

PMID:
19818809
7.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
8.
9.

Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats.

Levin BE, Dunn-Meynell AA.

Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2222-8.

10.

Dietary sodium propionate affects mucosal immune parameters, growth and appetite related genes expression: Insights from zebrafish model.

Hoseinifar SH, Safari R, Dadar M.

Gen Comp Endocrinol. 2017 Mar 1;243:78-83. doi: 10.1016/j.ygcen.2016.11.008. Epub 2016 Nov 9.

PMID:
27838381
11.

The development of tolerance to drugs that suppress food intake.

Fernstrom JD, Choi S.

Pharmacol Ther. 2008 Jan;117(1):105-22. Epub 2007 Sep 20. Review.

PMID:
17950459
12.

Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.

Rodgers RJ, Holch P, Tallett AJ.

Pharmacol Biochem Behav. 2010 Nov;97(1):3-14. doi: 10.1016/j.pbb.2010.03.001. Epub 2010 Mar 7. Review.

PMID:
20214921
13.

Appetite suppressants: problems and pitfalls of drug discovery.

Levens N, Della-Zuana O.

Curr Opin Investig Drugs. 2003 Apr;4(4):384-5. No abstract available.

PMID:
12808875
14.

Appetite control and obesity.

Wadikar DD, Premavalli KS.

Crit Rev Food Sci Nutr. 2012;52(10):949-56. doi: 10.1080/10408398.2010.514757. Review.

PMID:
22747082
15.
16.

Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Cheng CY, Chu JY, Chow BK.

Neuropsychopharmacology. 2011 Jan;36(2):459-71. doi: 10.1038/npp.2010.178. Epub 2010 Oct 6.

17.

5-HT(2C) receptor agonists and the control of appetite.

Halford JC, Harrold JA.

Handb Exp Pharmacol. 2012;(209):349-56. doi: 10.1007/978-3-642-24716-3_16. Review.

PMID:
22249823
18.

The effects of high fat on central appetite genes in Wistar rats: a microarray analysis.

Xu RY, Wan YP, Tang QY, Wu J, Cai W.

Clin Chim Acta. 2008 Nov;397(1-2):96-100. doi: 10.1016/j.cca.2008.07.027. Epub 2008 Aug 5.

PMID:
18721800
19.

Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite.

Romano A, Coccurello R, Giacovazzo G, Bedse G, Moles A, Gaetani S.

Biomed Res Int. 2014;2014:203425. doi: 10.1155/2014/203425. Epub 2014 Apr 3.

20.

Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs.

Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin JP, Hutchinson TH.

J Pharmacol Toxicol Methods. 2008 May-Jun;57(3):176-87. doi: 10.1016/j.vascn.2008.01.004. Epub 2008 Feb 9.

PMID:
18337127

Supplemental Content

Support Center